Edge Conversion Launches Custom AI Systems to Supercharge Sales and Scale Growth for Small Businesses 
Capital Markets Malaysia Expands Simplified ESG Disclosure Guide with a GHG Emission Calculator for SMEs 
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets 
EUDR Solution From Source Intelligence Simplifies Deforestation Due Diligence 
Spacely AI Secures US $1 Million Seed Round to Supercharge Generative AI Design for Architects Worldwide T2 Biosystems to Unveil New Data at September Conferences
Leading rapid diagnostics company to share new research at industry conferences throughout Sepsis Awareness Month LEXINGTON,…
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and…
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and Nagy Habib, Ch.M., F.R.C.S. to the Scientific Advisory Board
Dr. Rossi is a world leader in the development of RNA interference, the Lidow Family…
Skye Bioscience Announces Special Virtual Investor Presentation
Skye Bioscience Investor Hour Please join us for a special investor presentation. SAN DIEGO, CA,…
Nkarta to Participate at Upcoming Investor Conference
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a…
Published Study Shows Healthy Extracts Breakthrough Nutraceutical Formulation, ACTIVATE, Naturally Enhances Key Brain Activity by 46%
UBN ACTIVATE™ UBN ACTIVATE™ is clinically proven to enhance brain function, improve cognition, memory, focus,…
Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21ˢᵗ
LAVAL, Québec, Sept. 14, 2021 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
SELLAS Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference on September 28th
NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
Vallon Pharmaceuticals Announces Formation of Scientific Advisory Board
– Inaugural appointments include globally renowned leaders and experts on attention-deficit/hyperactivity disorder (ADHD) and stimulant…
Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant depression
NEW YORK and BERLIN, Sept. 14, 2021 (GLOBE NEWSWIRE) — Perception Neuroscience (Perception), an atai…
Pyxis Oncology Appoints Jay M. Feingold, M.D., Ph.D., as Chief Medical Officer
Industry veteran strengthens Pyxis team with expertise in clinical development, medical affairs and antibody-drug conjugates…
Medicenna Doses First Patient in MDNA11 Phase 1/2 ABILITY Study
— Trial designed to assess safety, pharmacokinetics (PK), pharmacodynamics (PD), and anti-tumor activity of MDNA11…
Werewolf Therapeutics to Present at Upcoming Next-Gen Cytokine Therapeutics Summit
CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative…
Kronos Bio Appoints Marni Kottle as Senior Vice President of Corporate Communications and Investor Relations
SAN MATEO, Calif. and CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Kronos Bio, Inc….
Aprea Therapeutics to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Solid Tumors at ESMO Congress 2021
BOSTON, Sept. 14, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused…
Immunophotonics Announces Issuance of U.S. Patent Covering Lead Drug Candidate
ST. LOUIS and BERN, Switzerland, Sept. 14, 2021 (GLOBE NEWSWIRE) — Immunophotonics, Inc., a clinical-stage…
Nuvectis Pharma In-Licenses Exclusive Worldwide Rights to a Novel SRC/YES1 Inhibitor (NXP900) from the University of Edinburgh, Scotland
•NXP900 is a SRC/YES1 Kinase Inhibitor with a Novel and Differentiated Mechanism of Action. FORT…
Beyond Air® to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
GARDEN CITY, N.Y., Sept. 14, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a…
Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test
SAN DIEGO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology…
Dante Labs Announces Expansion of its Finance Team with the Appointment of Andre Nel as Chief Financial Officer, Dalila Rahmani as Chief Accounting Officer, Laura D’Angelo as VP Investor Relations and Omar Elbakshish as Senior Director
CAMBRIDGE, United Kingdom, Sept. 14, 2021 (GLOBE NEWSWIRE) — Dante Labs, a global leader in…